Neumann Mark
Insider CIK 1756211 · ITCI EVP, Chief Commercial Officer · MANE Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MANE Veradermics, Inc | A Award deriv | 2026-02-03 | 2026-02-05 | 102,885 | — | $0 | 102,885 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 13,133 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 17,916 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 8,742 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2025-04-02 | 2025-04-02 | 8,742 | — | $0 | 8,742 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 13,134 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2025-04-02 | 2025-04-02 | 13,134 | — | $0 | 13,134 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 22,727 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 17,485 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer | 2025-04-02 | 2025-04-02 | 52,811 | $132.00 | $6.97M | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2025-03-10 | 2025-03-10 | 7,345 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2025-03-10 | 2025-03-10 | 7,345 | — | $0 | 55,927 | SEC↗ |
| ITCI Intra-Cellular Therapies, | F Tax w/h | 2025-03-10 | 2025-03-10 | 3,116 | $131.24 | $408.9K | 52,811 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2025-03-06 | 2025-03-10 | 13,133 | — | $0 | 13,133 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2025-03-06 | 2025-03-10 | 13,133 | — | $0 | 54,154 | SEC↗ |
| ITCI Intra-Cellular Therapies, | F Tax w/h | 2025-03-06 | 2025-03-10 | 5,572 | $131.19 | $731.0K | 48,582 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2025-03-01 | 2025-03-04 | 8,742 | — | $0 | 17,485 | SEC↗ |
| ITCI Intra-Cellular Therapies, | F Tax w/h | 2025-03-01 | 2025-03-04 | 3,709 | $128.20 | $475.5K | 41,021 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2025-03-01 | 2025-03-04 | 8,742 | — | $0 | 44,730 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2025-02-03 | 2025-02-04 | 22,727 | — | $0 | 22,727 | SEC↗ |
| ITCI Intra-Cellular Therapies, | F Tax w/h | 2025-01-31 | 2025-02-04 | 4,729 | $127.00 | $600.6K | 35,988 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2025-01-31 | 2025-02-04 | 11,017 | — | $0 | 40,717 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-08-16 | 2024-08-20 | 18,714 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-08-16 | 2024-08-20 | 18,714 | $75.08 | $1.41M | 29,700 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-08-16 | 2024-08-20 | 18,714 | $36.89 | $690.4K | 48,414 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-11 | 2024-03-11 | 1,313 | $66.86 | $87.8K | 29,700 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-11 | 2024-03-11 | 1,729 | $65.92 | $114.0K | 31,013 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-11 | 2024-03-11 | 4,303 | $65.11 | $280.2K | 32,742 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-03-10 | 2024-03-11 | 7,345 | — | $0 | 7,345 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-03-10 | 2024-03-11 | 7,345 | — | $0 | 37,045 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-07 | 2024-03-11 | 4,496 | $66.95 | $301.0K | 29,700 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-03-07 | 2024-03-11 | 8,636 | $66.37 | $573.2K | 34,196 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-03-06 | 2024-03-08 | 13,132 | — | $0 | 26,266 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-03-06 | 2024-03-08 | 13,132 | — | $0 | 42,832 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2024-03-01 | 2024-03-05 | 26,227 | — | $0 | 26,227 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-26 | 2024-02-27 | 1,307 | $71.18 | $93.0K | 29,700 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-26 | 2024-02-27 | 2,341 | $70.70 | $165.5K | 31,007 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-26 | 2024-02-27 | 4,059 | $69.56 | $282.3K | 33,348 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-26 | 2024-02-27 | 200 | $68.03 | $13.6K | 37,407 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-02-23 | 2024-02-27 | 7,907 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-02-23 | 2024-02-27 | 7,907 | — | $0 | 37,607 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-02 | 2024-02-05 | 4,956 | $66.67 | $330.4K | 36,604 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-02 | 2024-02-05 | 6,904 | $67.49 | $466.0K | 29,700 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2024-02-01 | 2024-02-05 | 11,860 | — | $0 | 41,560 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-11-06 | 2023-11-08 | 26,754 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-11-06 | 2023-11-08 | 26,754 | $23.94 | $640.5K | 72,093 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-11-06 | 2023-11-08 | 26,754 | $55.98 | $1.50M | 45,339 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-11-06 | 2023-11-08 | 15,639 | $55.02 | $860.5K | 29,700 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-08-07 | 2023-08-09 | 55,300 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-08-07 | 2023-08-09 | 55,300 | $58.79 | $3.25M | 45,339 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-08-07 | 2023-08-09 | 55,300 | $18.59 | $1.03M | 100,639 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-28 | 2023-03-30 | 10,183 | $54.01 | $550.0K | 45,339 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-28 | 2023-03-30 | 5,421 | $54.86 | $297.4K | 55,522 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-13 | 2023-03-13 | 423 | $44.05 | $18.6K | 60,943 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-13 | 2023-03-13 | 3,335 | $45.10 | $150.4K | 61,366 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-03-10 | 2023-03-13 | 7,344 | — | $0 | 14,690 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-10 | 2023-03-13 | 6,750 | $43.50 | $293.6K | 59,157 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-10 | 2023-03-13 | 1,800 | $42.74 | $76.9K | 57,357 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-03-10 | 2023-03-13 | 7,344 | — | $0 | 64,701 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2023-03-09 | 2023-03-13 | 16,708 | — | $0 | 65,907 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2023-03-06 | 2023-03-08 | 39,398 | — | $0 | 39,398 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-03-01 | 2023-03-03 | 7,241 | $50.01 | $362.1K | 49,199 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-24 | 2023-02-27 | 4,046 | $47.12 | $190.6K | 56,440 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-02-23 | 2023-02-27 | 7,906 | — | $0 | 7,907 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-02-23 | 2023-02-27 | 7,906 | — | $0 | 60,486 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-21 | 2023-02-22 | 635 | $48.93 | $31.1K | 52,580 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-21 | 2023-02-22 | 123 | $47.32 | $5.8K | 53,215 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-02-21 | 2023-02-22 | 3,140 | $46.61 | $146.4K | 53,338 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-02-18 | 2023-02-22 | 11,139 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-02-18 | 2023-02-22 | 11,139 | — | $0 | 56,478 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-04-08 | 2022-04-08 | 86,348 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-04-08 | 2022-04-08 | 17,476 | $63.55 | $1.11M | 114,211 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-04-08 | 2022-04-08 | 14,885 | $65.14 | $969.6K | 45,339 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-04-08 | 2022-04-08 | 53,987 | $64.42 | $3.48M | 60,224 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-04-08 | 2022-04-08 | 86,348 | $12.73 | $1.10M | 131,687 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2022-03-10 | 2022-03-14 | 22,034 | — | $0 | 22,034 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2022-03-10 | 2022-03-14 | 17,916 | — | $0 | 17,916 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-24 | 2022-02-25 | 2,660 | $52.94 | $140.8K | 50,585 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-24 | 2022-02-25 | 3,875 | $52.03 | $201.6K | 46,710 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-24 | 2022-02-25 | 1,371 | $51.33 | $70.4K | 45,339 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-02-23 | 2022-02-25 | 7,906 | — | $0 | 15,813 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-02-23 | 2022-02-25 | 7,906 | — | $0 | 53,245 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-22 | 2022-02-23 | 6,532 | $55.60 | $363.2K | 49,946 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-02-22 | 2022-02-23 | 4,607 | $54.84 | $252.6K | 45,339 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-02-18 | 2022-02-23 | 11,139 | — | $0 | 11,139 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-02-18 | 2022-02-23 | 11,139 | — | $0 | 56,478 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-01-10 | 2022-01-11 | 13,935 | $40.80 | $568.5K | 49,591 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-01-10 | 2022-01-11 | 4,252 | $40.09 | $170.5K | 45,339 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-01-10 | 2022-01-11 | 2,761 | $41.74 | $115.2K | 63,526 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-01-08 | 2022-01-11 | 20,948 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-01-08 | 2022-01-11 | 20,948 | — | $0 | 66,287 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-10-18 | 2021-10-19 | 4,288 | $40.77 | $174.8K | 47,797 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-10-18 | 2021-10-19 | 1,958 | $39.44 | $77.2K | 45,839 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-10-18 | 2021-10-19 | 500 | $38.88 | $19.4K | 45,339 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-10-18 | 2021-10-19 | 6,702 | $41.49 | $278.1K | 52,085 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-10-15 | 2021-10-19 | 13,448 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-10-15 | 2021-10-19 | 13,448 | — | $0 | 58,787 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2021-02-23 | 2021-02-25 | 23,719 | — | $0 | 23,719 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2021-02-23 | 2021-02-25 | 18,714 | — | $0 | 18,714 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-02-19 | 2021-02-22 | 4,584 | $39.26 | $180.0K | 45,939 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-02-19 | 2021-02-22 | 600 | $38.90 | $23.3K | 45,339 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-02-18 | 2021-02-22 | 11,139 | — | $0 | 22,278 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-02-18 | 2021-02-22 | 11,139 | — | $0 | 50,523 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2021-01-11 | 2021-01-12 | 9,684 | $32.02 | $310.1K | 39,384 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2021-01-08 | 2021-01-12 | 20,948 | — | $0 | 20,948 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2021-01-08 | 2021-01-12 | 20,948 | — | $0 | 49,068 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2020-10-16 | 2020-10-16 | 6,792 | $26.80 | $182.0K | 28,120 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2020-10-15 | 2020-10-16 | 13,448 | — | $0 | 13,448 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2020-10-15 | 2020-10-16 | 13,448 | — | $0 | 34,912 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2020-02-18 | 2020-02-20 | 26,754 | — | $0 | 26,754 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2020-02-18 | 2020-02-20 | 33,417 | — | $0 | 33,417 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2020-01-08 | 2020-01-10 | 20,947 | — | $0 | 41,896 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2020-01-08 | 2020-01-10 | 20,947 | — | $0 | 27,621 | SEC↗ |
| ITCI Intra-Cellular Therapies, | J Other | 2020-01-08 | 2020-01-10 | 6,157 | $26.34 | $162.2K | 21,464 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2019-10-16 | 2019-10-17 | 6,774 | $8.25 | $55.9K | 6,674 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2019-10-15 | 2019-10-17 | 13,448 | — | $0 | 26,896 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2019-10-15 | 2019-10-17 | 13,448 | — | $0 | 13,448 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2019-01-08 | 2019-01-10 | 62,843 | — | $0 | 62,843 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2019-01-08 | 2019-01-10 | 86,348 | — | $0 | 86,348 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2018-10-15 | 2018-10-17 | 40,344 | — | $0 | 40,344 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2018-10-15 | 2018-10-17 | 55,300 | — | $0 | 55,300 | SEC↗ |